ASTRAZENECA has struck a deal worth up to $400 million with Japan’s Takeda Pharmaceutical to co-develop and commercialise a potential treatment for Parkinson’s disease.
Source: Daily Express :: Finance Feed http://ift.tt/2xx8LaF
AstraZeneca strikes £309 million deal with Japan’s Takeda Pharmaceutical
ASTRAZENECA has struck a deal worth up to $400 million with Japan’s Takeda Pharmaceutical to co-develop and commercialise a potential treatment for Parkinson’s disease.
Source: Daily Express :: Finance Feed http://ift.tt/2xx8LaF
EmoticonEmoticon